Afuco™ Anti-Human CCR4 ADCC Therapeutic Antibody (AT008), ADCC Enhanced
Anti-CCR4 ADCC Enhanced Antibody (AT008) is an ADCC enhanced antibody produced by our Afuco™ platform. AT008 is a GPCR antibody program for chemokine receptor CCR4 as a potential treatment targeted against certain haematological and solid cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-096CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CCR4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |